Dr Alberto Zamo speaks with ecancertv at BSH 2016 about current affairs in haematopathology.

Currently, few laboratories have access to next generation sequencing technology, influencing regional abilities to reach accurate diagnoses.

Dr Zamo describes the promising potential for affordable access to genomic techniques and improved patient risk stratification in the near future. 

ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.